BioMall
Brand Store/BDB Bioscience/BD HorizonTM RY586 Mouse Anti-Human CD309 (VEGFR-2)
BD HorizonTM RY586 Mouse Anti-Human CD309 (VEGFR-2)
GENERAL CATALOGUE

BD HorizonTM RY586 Mouse Anti-Human CD309 (VEGFR-2)

568812 · 100 Tests

BDB Bioscience · Cat: 568812

₹360 – ₹550 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 568812
Category: reagents
Pack Size: 100 Tests
Brand: BDB Bioscience

Description

Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Show More Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Show More Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents